These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 34651199)

  • 1. Mega randomized clinical trials: a definitive solution or a double-edged sword?
    Lemaitre F; Laviolle B
    Eur J Clin Pharmacol; 2022 Feb; 78(2):305-306. PubMed ID: 34651199
    [No Abstract]   [Full Text] [Related]  

  • 2. COVID-19 clinical trials: Ethical and scientific consequences of the RECOVERY trial results.
    Dal-Ré R; Porcher R; Gluud C
    Basic Clin Pharmacol Toxicol; 2020 Dec; 127(6):445-447. PubMed ID: 32931136
    [No Abstract]   [Full Text] [Related]  

  • 3. Producing and using timely comparative evidence on drugs: lessons from clinical trials for covid-19.
    Naci H; Kesselheim AS; Røttingen JA; Salanti G; Vandvik PO; Cipriani A
    BMJ; 2020 Oct; 371():m3869. PubMed ID: 33067179
    [No Abstract]   [Full Text] [Related]  

  • 4. COVID: treatment trials are still urgent.
    Rauchman S
    Nature; 2021 Jun; 594(7861):26. PubMed ID: 34075245
    [No Abstract]   [Full Text] [Related]  

  • 5. Covid-19 vaccine trial protocols released.
    Doshi P
    BMJ; 2020 Oct; 371():m4058. PubMed ID: 33087395
    [No Abstract]   [Full Text] [Related]  

  • 6. Multigroup, Adaptively Randomized Trials Are Advantageous for Comparing Coronavirus Disease 2019 (COVID-19) Interventions.
    Magaret AS; Jacob ST; Halloran ME; Guthrie KA; Magaret CA; Johnston C; Simon NR; Wald A
    Ann Intern Med; 2020 Oct; 173(7):576-577. PubMed ID: 32525715
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rigorous Randomized Controlled Trial Implementation in the Era of COVID-19.
    Oldenburg CE; Doan T
    Am J Trop Med Hyg; 2020 Jun; 102(6):1154-1155. PubMed ID: 32297590
    [No Abstract]   [Full Text] [Related]  

  • 8. Generating randomized trial evidence to optimize treatment in the COVID-19 pandemic.
    Cheng MP; Lee TC; Tan DHS; Murthy S
    CMAJ; 2020 Apr; 192(15):E405-E407. PubMed ID: 32336678
    [No Abstract]   [Full Text] [Related]  

  • 9. Discussing Evidence in the Fog of the Pandemic.
    Hope AA; Munro CL
    Am J Crit Care; 2020 Jul; 29(4):246-248. PubMed ID: 32369547
    [No Abstract]   [Full Text] [Related]  

  • 10. Safety and Efficacy of Imatinib for Hospitalized Adults with COVID-19: A structured summary of a study protocol for a randomised controlled trial.
    Emadi A; Chua JV; Talwani R; Bentzen SM; Baddley J
    Trials; 2020 Oct; 21(1):897. PubMed ID: 33115543
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The SARS-CoV-2 Ivermectin Navarra-ISGlobal Trial (SAINT) to Evaluate the Potential of Ivermectin to Reduce COVID-19 Transmission in low risk, non-severe COVID-19 patients in the first 48 hours after symptoms onset: A structured summary of a study protocol for a randomized control pilot trial.
    Chaccour C; Ruiz-Castillo P; Richardson MA; Moncunill G; Casellas A; Carmona-Torre F; Giráldez M; Mota JS; Yuste JR; Azanza JR; Fernández M; Reina G; Dobaño C; Brew J; Sadaba B; Hammann F; Rabinovich R
    Trials; 2020 Jun; 21(1):498. PubMed ID: 32513289
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hydroxychloroquine efficacy and safety in preventing SARS-CoV-2 infection and COVID-19 disease severity during pregnancy (COVID-Preg): a structured summary of a study protocol for a randomised placebo controlled trial.
    González R; García-Otero L; Pons-Duran C; Marbán-Castro E; Goncé A; Llurba E; Gil MDM; Rodríguez-Zambrano MÁ; Chen H; Ramírez M; Bardají A; Menendez C
    Trials; 2020 Jul; 21(1):607. PubMed ID: 32616063
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Randomisation in clinical trials.
    Beller EM; Gebski V; Keech AC
    Med J Aust; 2002 Nov; 177(10):565-7. PubMed ID: 12429008
    [No Abstract]   [Full Text] [Related]  

  • 14. Treating COVID-19-Off-Label Drug Use, Compassionate Use, and Randomized Clinical Trials During Pandemics.
    Kalil AC
    JAMA; 2020 May; 323(19):1897-1898. PubMed ID: 32208486
    [No Abstract]   [Full Text] [Related]  

  • 15. Just the facts: updates in COVID-19 therapeutics.
    Long B; Liang SY; Rosenberg H; Hicks C; Gottlieb M
    CJEM; 2021 May; 23(3):283-285. PubMed ID: 33555601
    [No Abstract]   [Full Text] [Related]  

  • 16. COVID-19 vaccine trials: The use of active controls and non-inferiority studies.
    Fleming TR; Krause PR; Nason M; Longini IM; Henao-Restrepo AM
    Clin Trials; 2021 Jun; 18(3):335-342. PubMed ID: 33535811
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Deploying Randomized Controlled Trials during the COVID-19 Pandemic: Reason and Bayesian Designs.
    Zampieri FG
    Ann Am Thorac Soc; 2020 Aug; 17(8):937-938. PubMed ID: 32735169
    [No Abstract]   [Full Text] [Related]  

  • 18. Efficacy and safety of nelfinavir in asymptomatic and mild COVID-19 patients: a structured summary of a study protocol for a multicenter, randomized controlled trial.
    Hosogaya N; Miyazaki T; Fukushige Y; Takemori S; Morimoto S; Yamamoto H; Hori M; Kurokawa T; Kawasaki Y; Hanawa M; Fujii Y; Hanaoka H; Iwami S; Watashi K; Yamagoe S; Miyazaki Y; Wakita T; Izumikawa K; Yanagihara K; Mukae H; Kohno S;
    Trials; 2021 Apr; 22(1):309. PubMed ID: 33910617
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Review of randomized controlled trials: issues to consider when designing a trial.
    Pandis N
    Am J Orthod Dentofacial Orthop; 2013 Jun; 143(6):905-7. PubMed ID: 23726342
    [No Abstract]   [Full Text] [Related]  

  • 20. The WHO's chief scientist on a year of loss and learning.
    Swaminathan S
    Nature; 2020 Dec; 588(7839):583-585. PubMed ID: 33335314
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.